MAIA Biotechnology, Inc. (MAIA) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Analysts estimate Earnings Per Share (EPS) of $-1.49 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.05 vs est $-1.49 (beat +29.3%). 2025: actual $-0.70 vs est $-0.74 (beat +5.4%). Analyst accuracy: 76%.
